-
journal article
Welters MJ, Bijker MS, van den Eeden SJ, Franken KL, Melief CJ, Offringa R, van der Burg SH.
Vaccine. 2007 Feb 9;25(8):1379-89.
A systematic comparison of the immunostimulatory capacity of TLR 2, 3, 4, 5, 7 and 9 agonists and an agonistic CD40-specific antibody was performed in a single long peptide vaccination model. All adjuvants activated DC in vitro but not all induced a strong functional T-cell response in vivo. Optimal clonal CD8(+) T-cell expansion depended on the capacity of agonists to mature pro-inflammatory DC and the duration of their in vivo stimulatory effect. Strong agonists promoted the induction of both antigen-specific IFNgamma-producing CD4(+) T-helper cells and high num
...
-
journal article
Mantegazza AR, Savina A, Vermeulen M, Pérez L, Geffner J, Hermine O, Rosenzweig SD, Faure F, Amigorena S.
Blood. 2008 Dec 1;112(12):4712-22. Epub 2008 Aug 5.
The phagocyte NADPH oxidase (NOX2) is critical for the bactericidal activity of phagocytic cells and plays a major role in innate immunity. We showed recently that NOX2 activity in mouse dendritic cells (DCs) prevents acidification of phagosomes, promoting antigen cross-presentation. In order to investigate the role of NOX2 in the regulation of the phagosomal pH in human DCs, we analyzed the production of reactive oxygen species (ROS) and the phagosomal/endosomal pH in monocyte-derived DCs and macrophages (M(diameter)s) from healthy donors or patients with chroni
...
-
journal article
Ménard C, Blay JY, Borg C, Michiels S, Ghiringhelli F, Robert C, Nonn C, Chaput N, Taïeb J, Delahaye NF, Flament C, Emile JF, Le Cesne A, Zitvogel L.
Cancer Res. 2009 Apr 15;69(8):3563-9. Epub 2009 Apr 7.
Clinical outcomes of gastrointestinal stromal tumor (GIST)-bearing patients treated with imatinib mesylate (IM) are variable. Other than the site of mutation within the c-kit gene, prognostic features of GIST remain undefined. IM can exhibit off-target effects such as triggering natural killer (NK) cell activity. We addressed whether NK cell functions could predict long term survival with IM. NK cell functions were followed up in 77 GIST patients enrolled onto two phase III trials. "Immunologic responders" were defined as patients whose NK cell IFN-gamma values a
...
-
journal article
Terme M., Ullrich E., Chaput N., Zitvogel L.
Nat Immunol. 2008 May;9(5):486-94.
Natural killer (NK) cells influence innate and adaptive immune host defenses. Existing data indicate that manipulating the balance between inhibitory and activating NK receptor signals, the sensitivity of target cells to NK cell-mediated apoptosis, and NK cell cross-talk with dendritic cells might hold therapeutic promise. Efforts to modulate NK cell trafficking into inflamed tissues and/or lymph nodes, and to counteract NK cell suppressors, might also prove fruitful in the clinic. However, deeper investigation into the benefits of combination therapy, greater und
...
-
journal article
Buonocore S, Haddou NO, Moore F, Florquin S, Paulart F, Heirman C, Thielemans K, Goldman M, Flamand V.
J Leukoc Biol. 2008 Sep;84(3):713-20. Epub 2008 Jun 20.
Overexpression of CD95 (Fas/Apo-1) ligand (CD95L) has been shown to induce T cell tolerance but also, neutrophilic inflammation and rejection of allogeneic tissue. We explored the capacity of dendritic cells (DCs) genetically engineered to overexpress CD95L to induce an antitumor response. We first found that DCs overexpressing CD95L, in addition to MHC class I-restricted OVA peptides (CD95L-OVA-DCs), induced increased antigen-specific CD8(+) T cell responses as compared with DCs overexpressing OVA peptides alone. The enhanced T cell responses were associated wit
...
-
journal article
Robbins SH, Walzer T, Dembélé D, Thibault C, Defays A, Bessou G, Xu H, Vivier E, Sellars M, Pierre P, Sharp FR, Chan S, Kastner P, Dalod M.
Genome Biol. 2008 Jan 24;9(1):R17. [Epub ahead of print]
ABSTRACT: BACKGROUND: Dendritic cells (DCs) are a complex group of cells that play a critical role in vertebrate immunity. Lymph-node resident DCs (LN-DCs) are subdivided into conventional DC (cDC) subsets (CD11b and CD8alpha in mouse; BDCA1 and BDCA3 in human) and plasmacytoid DCs (pDCs). It is currently unclear if these various DC populations belong to a unique hematopoietic lineage and if the subsets identified in the mouse and human systems are evolutionary homologs. To gain novel insights into these questions, we sought conserved genetic signatures for LN-DC
...
-
journal article
Savina A., Jancic C., Hugues S., Guermonprez P., Vargas P., Cruz Moura I., Lennon-Duménil A., Seabra M.C., Raposo G. and Amigorena S.
Cell, 126, 205-218 (2006)
To initiate adaptative cytotoxic immune responses, proteolytic peptides derived from phagocytosed antigens are presented by dendritic cells (DCs) to CD8+ T lymphocytes through a process called antigen "crosspresentation." The partial degradation of antigens mediated by lysosomal proteases in an acidic environment must be tightly controlled to prevent destruction of potential peptides for T cell recognition. We now describe a specialization of the phagocytic pathway of DCs that allows a fine control of antigen processing. The NADPH oxidase NOX2 is recruited to the
...
-
journal article
Liso A., Colau D., Benmaamar R., De Groot A., Martin W., Benedetti R., Specchia G., Martelli M.P., Coulie P., Falini B.
Leukemia, epub (2007)
-
journal article
Cambi A, Joosten B, Koopman M, de Lange F, Beeren I, Torensma R, Fransen JA, Garcia-Parajó M, van Leeuwen FN, Figdor CG.
Mol Biol Cell. 2006 Oct;17(10):4270-81. Epub 2006 Jul 19.
The beta2-integrin LFA-1 facilitates extravasation of monocytes (MOs) into the underlying tissues, where MOs can differentiate into dendritic cells (DCs). Although DCs express LFA-1, unlike MOs, they cannot bind to ICAM-1. We hypothesized that an altered integrin organization on the DC plasma membrane might cause this effect and investigated the relationship between membrane organization and function of LFA-1 on MOs and DCs. High-resolution mapping of LFA-1 surface distribution revealed that on MOs LFA-1 function is associated with a distribution in well-defined
...
-
journal article
Widén K, Mozaffari F, Choudhury A, Mellstedt H.
Ann Oncol. 2008 Sep;19 Suppl 7:vii241-7.
Clinical trials have demonstrated from time to time that cancer vaccines can elicit effective antitumour cellular immunity that may translate to clinical benefit for cancer patients. Additionally, several monoclonal antibodies currently used for treating cancer patients mediate their effects through mechanisms like antibody-dependent cellular cytotoxicity (ADCC) and therefore rely on an effective immune system. Patients with advanced tumours, however, are known to have aberrations in their immune function. Improving the clinical effectiveness of immunotherapy the
...
-
journal article
Saccani A., Schioppa T., Porta C., Biswas S.K., Nebuloni M., Vago L., Bottazzi B., Colombo M.P., Mantovani A., Sica A.
Cancer Res. 2006 Dec 1;66(23):11432-40.
Tumor-associated macrophages (TAM) are a major inflammatory infiltrate in tumors and a major component of the protumor function of inflammation. TAM in established tumors generally have an M2 phenotype with defective production of interleukin-12 (IL-12) and high IL-10. Here, we report that defective responsiveness of TAM from a murine fibrosarcoma and human ovarian carcinoma to M1 activation signals was associated with a massive nuclear localization of the p50 nuclear factor-kappaB (NF-kappaB) inhibitory homodimer. p50 overexpression inhibited IL-12 expression in
...
-
journal article
Grosu P, Townsend JP, Hartl DL, Cavalieri D.
Genome Res. 2002 Jul;12(7):1121-6.
We have developed a new tool to visualize expression data on metabolic pathways and to evaluate which metabolic pathways are most affected by transcriptional changes in whole-genome expression experiments. Using the Fisher Exact Test, the method scores biochemical pathways according to the probability that as many or more genes in a pathway would be significantly altered in a given experiment by chance alone. This method has been validated on diauxic shift experiments and reproduces well known effects of carbon source on yeast metabolism. The analysis is implemen
...
-
journal article
Sapoznikov A, Pewzner-Jung Y, Kalchenko V, Krauthgamer R, Shachar I, Jung S.
Nat Immunol. 2008 Apr;9(4):388-95. Epub 2008 Mar 2.
Beyond its established function in hematopoiesis, the bone marrow hosts mature lymphocytes and acts as a secondary lymphoid organ in the initiation of T cell and B cell responses. Here we report the characterization of bone marrow-resident dendritic cells (bmDCs). Multiphoton imaging showed that bmDCs were organized into perivascular clusters that enveloped blood vessels and were seeded with mature B lymphocytes and T lymphocytes. Conditional ablation of bmDCs in these bone marrow immune niches led to the specific loss of mature B cells, a phenotype that could be
...
-
journal article
Denkberg G, Stronge VS, Zahavi E, Pittoni P, Oren R, Shepherd D, Salio M, McCarthy C, Illarionov PA, van der Merwe A, Besra GS, Dellabona P, Casorati G, Cerundolo V, Reiter Y.
Eur J Immunol. 2008 Mar;38(3):829-40.
The glycolipid alpha-galactosylceramide (alpha-GalCer) is a potent activator of invariant natural killer T (iNKT) cells and has been shown to be an effective agent against cancer, infections and autoimmune diseases. The effectiveness of alpha-GalCer and its alkyl chain analogues depends on efficient loading and presentation by the antigen-presenting molecule CD1d. To monitor the ability of CD1d to present the glycolipids, we have used a phage display strategy to generate recombinant antibodies with T cell receptor-like (TCRL) specificity against the human CD1d (h
...
-
journal article
Kenter GG, Welters MJ, Valentijn AR, Lowik MJ, Berends-van der Meer DM, Vloon AP, Drijfhout JW, Wafelman AR, Oostendorp J, Fleuren GJ, Offringa R, van der Burg SH, Melief CJ.
Clin Cancer Res. 2008 Jan 1;14(1):169-77.
PURPOSE: To determine the toxicity, safety, and immunogenicity of a human papillomavirus 16 (HPV16) E6 and E7 long peptide vaccine administered to end-stage cervical cancer patients. EXPERIMENTAL DESIGN: Three groups of end-stage cervical cancer patients (in total n = 35) were s.c. vaccinated with HPV16 E6 combined with or separated from HPV16 E7 overlapping long peptides in Montanide ISA-51 adjuvant, four times at 3-week intervals. Group 1 received 300 microg/peptide at a single site and group 2 received 100 microg/peptide of the E6 peptides in one limb and 300
...
-
report
AN M. T. VAN NUFFEL
Despite the immunogenic nature of malignant melanoma and the reported induction of vaccine-induced cellular immune responses, limited clinical success has been achieved so far. The maturation status of the dendritic cells (DC) plays a pivotal role in their capacity to induce tumor-eradicating T cells. Recently, we have shown that so-called ‘TriMixDC’ have an improved T cell stimulatory capacity in vitro (Bonehill et al, Mol. Ther.). These TriMixDC are immature DCs (iDC) electroporated with mRNAs encoding CD40ligand (CD40L), CD70, a constitutive active form of
...
-
report
EWA SKOTNICKA
Peripheral T cell tolerance, mediated by antigen-presenting steady state dendritic cells, is thought to significantly contribute to the prevention of autoimmunity. We set out to analyze the involvement of FoxP3+ regulatory T-cells, which are known to be important for maintenance of self-tolerance, in dendritic cell-induced peripheral tolerance of T-cells.
Most autoreactive T cells are deleted in the thymus. Peripheral autoreactive T cells are controlled by peripheral tolerance, which acts through unresponsiveness/anergy, regulation/suppression and deletion. CD4+
...
-
report
ISABEL POSCHKE
I have been registered as a PhD student at the Karolinska Institute on the 31th of May, 2007 and expect to finish my PhD in June 2011.
Project 1 - Preparation and immunomontioring of a clinical trial in patients with advanced melanoma ? collaboration with Carl Figdor
Patients will receive a DC vaccination regimen (3 vaccinations at weekly intervals) followed by 3 adoptive transfers of autologous in vitro expanded T cells. This novel approach combines in vivo priming by the DC vaccine with passive immunotherapy by lymphocyte infusion.
Patients will undergo surg
...
-
report
Lisa Rizzetto
Predicted finish date for my PhD: February 2010
Our projects focuses on computational methods for the reconstruction of signalling pathways and the integration of gene expression data with existing biological information. In particular we target the response of dendritic cells to pathogenic and non pathogenic yeasts on a whole genome scale. At the same time our role in DC-THERA is to collaborate with bioinformaticians and with experimentalists for the solution of genomics problems that require highly interdisciplinary skills. We are also involved in the develop
...
-
report
MADELEINE HIPP
I will finish my PhD probably in 2010.
Abstract:
Toll-like receptors (TLRs) are important receptors of the innate immune system able to respond to molecular patterns borne by microbial and viral pathogens. TLR3, TLR7 and TLR9 form a subset of TLRs that are localized intracellularly and can recognize nucleic acids to initiate antiviral immune responses. Among these TLRs, TLR7 is triggered by viral or bacterial single stranded RNA (ssRNA) and mediates responses to RNA viruses. However, self-RNA can in some instances also activate TLR7, leading to the development o
...